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Frailty prevalence in older adults has been reported but is largely unknown inmiddle-aged adults.We determined the prevalence of
frailty indicators among middle-aged and older adults from a general Swiss population characterized by universal health insurance
coverage and assessed the determinants of frailty with a special focus on socioeconomic status. Participants aged 50 and more
from the population-based 2006–2010 Bus Sante´ study were included (𝑁 = 2,930). Four frailty indicators (weakness, shrinking,
exhaustion, and low activity) were measured according to standard definitions. Multivariate logistic regressions were used to
determine associations. Overall, 63.5%, 28.7%, and 7.8% participants presented no frailty indicators, one frailty indicator, and two
or more frailty indicators, respectively. Among middle-aged participants (50–65 years), 75.1%, 22.2%, and 2.7% presented 0, 1, and
2 or more frailty indicators.The number of frailty indicators was positively associated with age, hypertension, and current smoking
and negatively associated with male gender, body mass index, waist-to-hip ratio, and serum total cholesterol level. Lower income
level but not educationwas associatedwith higher number of frailty indicators. Frailty indicators are frequently encountered in both
older and middle-aged adults from the Swiss general population. Despite universal health insurance coverage, household income
is independently associated with frailty.
1. Introduction
Frailty is a biological syndrome that results from cumulative
declines across multiple physiologic systems and causes
vulnerability to adverse outcomes [1]. Frailty predicts adverse
outcomes such as hospitalization and death [2, 3] and is con-
sidered as a modifiable predictor of disability [4]. Frailty is
partly reversible, especially in its initial phase [4], and the
identification of frail adults followed by effective interven-
tions could potentially prevent disability and other adverse
outcomes. Studies among older adults, generally defined as
people aged 65 years and over, suggest that the prevalence
of frailty is variable and has been reported to range from
4.0% to 59.1% of studied populations [5]. Comparable infor-
mation about the prevalence of frailty among populations
younger than 65 years is limited [6]. Gathering data among
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middle-aged subjects is important given that frailty pheno-
type finds its ideal application in nondisabled subjects [7].
Socioeconomic status (SES) may contribute to the vari-
ability in prevalence among older individuals [8–10]. Life
(including early life) course social and health conditions
linked to frailty among older adults are often present earlier
in adulthood [11, 12]. However the association of SES with
frailty among middle-aged adults has not been extensively
studied. We address these issues in this study by describing
the prevalence of frailty and assessing the association between
frailty and lower SES in a population-based study of middle-
aged and older adults with uniform access to healthcare.
2. Methods
2.1. Study Population. Weused data from the Bus Sante´ study.
The Bus Sante´ study is an annual cross-sectional population-
based survey that collects information on cardiovascular
risk factors in the Canton of Geneva (Switzerland) [13].
Subjects are randomly selected throughout each survey year
to generate a representative sample of the canton’s noninstitu-
tionalized residents aged 35 years and older. Eligible subjects
are identified using a list of legal residents provided by the
local government. Stratified random sampling is used to
select participants by gender within each 10-year age stratum,
selecting the number of participants that is proportional to
the corresponding population distribution. The 2006–2010
participation rates varied between 60% and 68%. The Bus
Sante´ study complied with the Declaration of Helsinki and
was approved by the Institutional Ethics Committee of the
University of Geneva. All participants gave written informed
consent.
2.2. Data Collection. Participants are examined by trained
health professionals. Each participant completes several self-
administered, standardized questionnaires. Anthropometric
measures, including height, weight, and waist circumference,
and blood pressure (BP) are obtained following specified
protocols. In a temperature-controlled room, body weight
was measured with the subject lightly dressed without shoes
using a medical scale (precision 0.5 kg), and standing height
is measured using a medical gauge (precision 1 cm). Body
mass index (BMI) was defined as weight/height2. Waist and
hip circumferences (cm) were measured in duplicate with an
anthropometric tape while the subjects were wearing light
clothing.Waist circumference wasmeasured at theminimum
circumference between the iliac crest and the rib cage. Hip
circumference was measured at the maximum protuberance
of the buttocks, and the waist-to-hip ratio was calculated.
BP was measured three times on the right arm after at least
10min rest in the seated position, using a clinically val-
idated automated oscillometric device (Omron HEM-907,
Matsusaka, Japan) with a standard cuff or a large cuff if
arm circumference was ≥33 cm. The average of the three BP
readings was used for analyses. Hypertension was defined as
mean SBP ≥ 140mmHg or mean DBP ≥ 90mmHg or
presence of antihypertensive medication.
Smoking was defined as present if a participant reported
to be a current smoker at the time of examination. Diabetes
was defined as a fasting glucose ≥7mmol/L and/or the pres-
ence of antidiabetic drug treatment (insulin or oral drugs).
Other cardiovascular diseases (CVDs) and risk factors were
defined by affirmative answers to the following questions:
“Have you ever been told that you had high choles-
terol/myocardial infarction/arterial thrombosis?”
Glucose, total and HDL plasma cholesterol, and triglyc-
erides were assayed by using commercially available enzy-
matic kits (Bayer Technicon Diagnostics, CV 1.4%, 1.2%, and
1.5%, for glucose, cholesterol, and triglycerides, resp.).
2.3. Frailty Indicators. Frailty indicators were assessed by
using standardized measures in participants aged 50 or
more. These indicators approximated four of the five frailty
constructs described by Fried et al. [2]. Frailty indicators used
are defined below.
2.3.1. Weakness. Weakness was defined as the gender specific
and BMI adjusted lowest 20% grip strength.The grip strength
test was performed on the right hand, using the mean of
the three measurements with a hydraulic hand dynamometer
(Baseline Evaluation Instruments, New York).
2.3.2. Low Activity. Low activity was defined as the gender
specific lowest 20% energy expenditure. Energy expenditure
in kcal/week was measured using a validated physical activity
frequency questionnaire (PAFQ) [14].
2.3.3. Shrinking. Shrinking was defined as self-reported
unintentional weight loss. Participants were asked whether
they had lost unintentionally weight during the past year: “In
the last 12-month [sic], have you unintentionally lost weight?”
2.3.4. Exhaustion. Exhaustion was defined as self-reported
exhaustion. Participants were asked whether they had a
feeling of generalized weakness in the past year: “In the last
12-month [sic], did you have a feeling of generalizedweakness
or lack of energy?”
2.4. Socioeconomic Status. Self-reported education and
income were used to characterize SES. Education level and
monthly household income were categorized into 3 groups
(education: high (≥13 years), middle (9–12 years), and low
(<8 years); monthly household income: <4,999CHF, 5,000–
9499CHF, and >9,500CHF (1 CHF ≈ 1 US$ in September
2014)).
2.5. Statistical Analyses. To account for the survey year-
specific age and gender structure estimates and associations
were weighted using the 2010 Geneva Census population.
Weighted means (standard errors, SE) and frequencies of
study variables were calculated. Participants were grouped
into three groups according to the number of frailty indi-
cators: 0 frailty indicators, 1 frailty indicator, and 2 or more
frailty indicators. The latter category was used because the
number of participantswith 3 or 4 frailty indicatorswas small.
To account for the sampling procedure, survey procedures
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Table 1: Participants’ characteristics overall and by type of frailty indicator present, Bus Sante´ study, Geneva 2006–2010,𝑁 = 2,930.
Participant characteristic
All
𝑁 = 2930
100%
Weakness
𝑁 = 586
13.8%
Exhaustion
𝑁 = 197
7.0%
Shrinking
𝑁 = 188
6.3%
Low activity
𝑁 = 586
18.3%
Age, years, mean (SE) 60.0 (0.1) 72.8 (0.1) 58.5 (0.5) 60.9 (0.6) 63.4 (0.3)
Age 50–65 years (%) 73.6 0.0 7.6 5.7 14.4
Age ≥ 65 years (%) 26.4 52.2 5.4 7.7 29.0
Women (%) 51.0 54.2 66.1 61.5 53.6
Swiss nationality (%) 78.8 79.4 76.9 74.7 79.0
Education level (%)
Low 15.6 23.9 16.8 25.7 17.8
Middle 45.5 47.4 41.8 44.1 46.0
High 38.9 28.7 41.4 30.3 36.2
Household income (%)
<4999 22.7 47.6 35.7 35.8 28.5
5000–9499 41.9 38.8 32.4 36.6 38.8
>9500 35.4 13.7 31.9 27.6 32.6
Hypertension (%) 47.5 70.2 53.4 49.9 53.1
Diabetes (%) 6.6 9.1 8.6 8.1 7.3
Myocardial infarction (%) 2.4 4.9 2.0 3.2 2.5
Angina pectoris (%) 2.7 4.9 5.4 4.4 2.9
Arterial obstruction (%) 2.9 5.6 8.1 4.6 2.7
Current smoker (%) 15.9 9.8 19.5 27.9 17.4
Body mass index, kg/m2, mean (SE) 26.1 (0.2) 26.4 (0.2) 28.0 (1.5) 24.9 (0.4) 24.7 (0.6)
Waist-to-hip ratio, mean (SE) 0.88 (0.00) 0.90 (0.00) 0.87 (0.01) 0.86 (0.01) 0.87 (0.01)
Serum total cholesterol, mmol/L, mean (SE) 5.63 (0.02) 5.58 (0.04) 5.59 (0.07) 5.51 (0.07) 5.60 (0.04)
Serum HDL cholesterol, mmol/L, mean (SE) 1.45 (0.01) 1.47 (0.02) 1.43 (0.03) 1.48 (0.03) 1.50 (0.02)
Serum triglycerides, mmol/L, mean (SE) 1.31 (0.02) 1.24 (0.02) 1.43 (0.08) 1.30 (0.07) 1.27 (0.03)
(SAS surveyfreq, surveymeans, and surveyreg) were used
with the weights option added for each procedure using the
2010 Geneva Census population age and gender structures
as weights. We compared groups using the Rao-Scott Chi-
square test and F test for categorical and continuous variables,
respectively.
We used polytomous multivariate logistic regression to
determine and test the associations of potential factors,
including socioeconomic factors, CVD, and cardiovascular
risk factors, with the number of frailty indicators (1 frailty
indicator versus 0, 2+ frailty indicators versus 0). Polytomous
logistic regression modeling allows for simultaneous estima-
tion of the probability ofmultiple outcomes.Middle-aged and
older categories were defined as age of 50–64.9 years and
≥65 years, respectively. To determine whether the adjusted
associations of SES (i.e., household income and education)
with frailty indicators were different in middle-age and
older participants, statistical interaction of age category with
household income and education was tested, respectively.
Citizenship was self-reported and categorized as Swiss or
non-Swiss. Analyses were limited to participants with all
variables of interest available.
All 𝑃 values were 2-tailed with significance set at <0.05.
All analyses were performed using SAS software version 9.2
(SAS Institute, Inc., Cary, North Carolina).
3. Results
3.1. Participants’ Characteristics. Out of the 3,117 subjects
aged 50 years and more who participated in the Bus Sante´
study between 2006 and 2010, 2,930 (95.0%) were included
in the analyses. The major reason for exclusion was absence
of blood sample. Participants’ characteristics are presented
in Table 1. Overall mean (SE) age was 60.0 (0.1) and 26.4%
were aged 65 years or more. Half were women and 78.8%
were Swiss. Hypertension and diabetes were present in
47.5% and 6.6%, respectively. Monthly household income of
<4,999CHF, 5,000–9499CHF, and>9,500CHFwas reported
by 23%, 42%, and 35% of the cohort.
3.2. Frailty Indicators. Low activity and weakness were the
most frequently observed frailty indicators; 18.3% and 13.8%
of the participants presented low activity and weakness,
respectively. Exhaustion was reported in 7.0% and shrinking
in 6.3% (Table 1). Among middle-aged participants exhaus-
tion, shrinking, and low activity were present in 7.6%, 5.7%,
and 14.4%, respectively. No middle-aged participant pre-
sented weakness. Among participants aged 65 ormore, weak-
ness, exhaustion, shrinking, and low activity were present in
52.2%, 5.4%, 7.7%, and 29.0%, respectively. Among the 2,930
participants, 0, 1, or 2 or more frailty indicators were present
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Table 2: Participants’ characteristics by the number of frailty indicators present, Bus Sante´ study, Geneva, 2006–2010,𝑁 = 2,930.
Participant characteristic
0 frailty indicator
𝑁 = 1711
63.5%
1 frailty indicator
𝑁 = 921
28.7%
2 or more frailty indicators
𝑁 = 298
7.8% 𝑃 value
∗
% or mean (SE) % or mean (SE) % or mean (SE)
Age, years, mean (SE) 57.5 (0.1) 63.0 (0.3) 68.8 (0.5) <0.0001
Women (%) 47.8 56.1 57.8 <0.0001
Age 50–65 years (%) 87.1 57.2 24.7 <0.0001
Age ≥ 65 years (%) 12.9 42.8 75.3 <0.0001
Swiss nationality (%) 78.5 80.3 75.1 0.183
Education level (%)
Low 13.4 18.0 24.4
<0.0001Middle 44.9 47.6 42.4
High 41.6 34.4 33.2
Household income (%)
<4999 16.6 28.8 49.0
<0.00015000–9499 43.5 41.5 31.0
>9500 39.9 29.7 20.1
Hypertension (%) 42.5 53.6 64.9 <0.0001
Diabetes (%) 5.8 7.5 8.8 0.069
Myocardial infarction (%) 2.1 2.9 3.6 0.170
Angina pectoris (%) 2.1 3.2 5.1 0.009
Cerebral or legs vascular obstruction (%) 2.2 3.7 5.6 0.001
Current smoker (%) 15.4 16.9 16.6 0.569
Body mass index, kg/m2, mean (SE) 26.3 (0.2) 25.7 (0.2) 26.0 (1.3) 0.076
Waist-to-hip ratio, mean (SE) 0.89 (0.00) 0.88 (0.00) 0.88 (0.01) 0.326
Serum total cholesterol, mmol/L, mean (SE) 5.64 (0.02) 5.65 (0.03) 5.48 (0.06) 0.027
Serum HDL cholesterol, mmol/L, mean (SE) 1.44 (0.01) 1.46 (0.01) 1.50 (0.02) 0.045
Serum triglycerides, mmol/L, mean (SE) 1.31 (0.02) 1.34 (0.03) 1.20 (0.03) 0.009
∗Rao-Scott Chi-square test for dichotomous and categorical variables and 𝐹 tests for continuous variables.
in 63.5%, 28.7%, and 7.8%, respectively (Table 2). Among
participants with 2 or more frailty indicators, 75.3% were of
the age of 65 and older. Among middle-aged participants
(50–64.9 years), 0, 1, and 2 or more frailty indicators were
present in 75.1%, 22.2%, and 2.7%, respectively. Among older
participants (≥65 years), 31.2%, 46.6%, and 22.3% had 0, 1,
and 2 or more frailty indicators (Figure 1).
Characteristics differed across group defined by the
number of frailty indicators present (Table 2). The mean
age and proportion of women and Swiss increased with the
increasing number of frailty indicators. Both education level
and monthly household income were associated with the
number of frailty indicators.
3.3. Determinants of the Number of Frailty Indictors. In
the polytomous multivariate logistic regression analyses, the
number of frailty indicators was positively associated with
age, hypertension, and current smoking status and negatively
associated with male gender, BMI, waist-to-hip ratio, and
total cholesterol (Table 3). The associations with male gender
and BMI were significant only when comparing participants
with 1 frailty indicator to participants without frailty indica-
tor.The association with total cholesterol was significant only
when comparing participantswith 2 ormore frailty indicators
to participants without frailty indicator.
Monthly household income was negatively and inde-
pendently associated with having more frailty indicators.
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Figure 1: Prevalence of participants with 0, 1, and 2 or more frailty
indicators, by age group, Bus Sante´ study, Geneva, 2006–2010, 𝑁 =
2,930.
Compared to participants with high monthly income level,
participants with low monthly income level were 31% more
likely to have 1 frailty indicator and two times more likely
to have 2 or more frailty indicators. Education level was
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Table 3: Multivariate associations (odds ratios OR, 95% CI) of characteristics with groups of number of frailty indicators, Bus Sante´ study,
Geneva, 2006–2010,𝑁 = 2,930.
Participant characteristic Frailty indicators group (ref = 0) OR (95% CI)
Age ≥ 65 years versus 50–65 years 2+ versus 0 19.4 (13.5–27.9)
∗
1 versus 0 4.9 (4.0–6.0)∗
Male 2+ versus 0 1.02 (0.66–1.59)
1 versus 0 0.72 (0.55–0.94)∗
Swiss nationality 2+ versus 0 0.77 (0.54–1.11)
1 versus 0 1.05 (0.83–1.32)
Education
Low 2+ versus 0 1.17 (0.75–1.83)
1 versus 0 1.28 (0.96–1.71)
Middle 2+ versus 0 0.82 (0.58–1.16)
1 versus 0 1.09 (0.89–1.35)
High 2+ versus 0 Ref
1 versus 0 Ref
Household income
<4999CHF 2+ versus 0 2.16 (1.36–3.44)
∗†
1 versus 0 1.31 (1.00–1.72)∗
5000–9499CHF 2+ versus 0 0.83 (0.55–1.27)
1 versus 0 0.94 (0.75–1.17)
>9500CHF 2+ versus 0 Ref
1 versus 0 Ref
Hypertension 2+ versus 0 1.88 (1.32–2.68)
∗
1 versus 0 1.40 (1.15–1.70)∗
Diabetes 2+ versus 0 1.19 (0.66–2.15)
1 versus 0 1.20 (0.83–1.72)
Myocardial infarction 2+ versus 0 0.78 (0.37–1.64)
1 versus 0 0.96 (0.54–1.71)
Angina pectoris 2+ versus 0 1.69 (0.83–3.43)
1 versus 0 1.24 (0.73–2.10)
Cerebral or legs vascular obstruction 2+ versus 0 1.70 (0.85–3.41)
†
1 versus 0 1.40 (0.81–2.44)
Current smoker 2+ versus 0 1.83 (1.19–2.81)
∗
1 versus 0 1.43 (1.03–1.68)∗
Body mass index, kg/m2 2+ versus 0 0.99 (0.89–1.10)
1 versus 0 0.96 (0.93–0.99)∗
Waist-to-hip ratio 2+ versus 0 0.02 (0.01–0.40)
∗
1 versus 0 0.73 (0.15–3.68)
Serum total cholesterol, mmol/L 2+ versus 0 0.82 (0.69–0.98)
∗
1 versus 0 0.98 (0.89–1.09)
Serum triglycerides, mmol/L 2+ versus 0 0.98 (0.76–1.27)
1 versus 0 1.12 (0.99–1.26)
Serum HDL cholesterol, mmol/L 2+ versus 0 1.57 (0.95–2.59)
1 versus 0 1.09 (0.82–1.47)
All models are adjusted for survey year, age, gender, Swiss nationality, education level, monthly household income, hypertension, diabetes, myocardial
infarction, angina pectoris, arterial obstruction, current smoking status, BMI, waist-to-hip ratio, serum total cholesterol, serum triglycerides, and serum HDL
cholesterol.
∗Statistically significant associations (𝑃 value < 0.05); †statistically significant interactions (𝑃 value < 0.05) with age category (50–64.9 years versus 65 years or
more).
(1 CHF ≈ 1 US$.)
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not independently associated with the number of frailty
indicators.
We found a statistical interaction of age category (50–
64.9 versus ≥65 years) with household income but not with
education. The positive associations of household income
with 2 ormore frailty indicatorswere stronger amongmiddle-
aged participants than older participants.
4. Discussion
Using population-based data froma Swiss regionwith univer-
sal health insurance coverage, we found that the prevalence
of frailty indicators was high in adults aged 50 or more.
Frailty indicators were frequently reported in middle-aged
adults (50–64.9 years) too; one-fourth had at least one frailty
indicator.
The prevalence of frailty indicators increased with age
which is in line with previous observations. Previous pop-
ulation-based studies have however rarely reported the preva-
lence of frailty among large enough sample of middle-aged
participants.Theprevalence of frailty in community-dwelling
middle-aged and older Europeans participating in a large
survey in 2004 has been reported; it ranged from 5.8% to
27.3% [6]. Compared to other countries, Switzerland was
characterized by a low prevalence of frailty. Of note, only
882 participants were included in the Swiss part of the 2004
survey and the participation rate was low (37.6%). Out of
the 882, only 470 participants were of the age of 50–65 yrs.
Among thismiddle-aged group, the prevalence of exhaustion,
weakness, shrinking, and low activity was 25.4%, 2.5%, 5.2%,
and 11.2%, respectively [6]. Thirty-six percent and 1.3% were
prefrail (1-2 frailty indicators) and frail (3+ frailty indicators),
respectively [6]. Using a larger sample in an urban region of
Switzerland (Geneva), our results further suggest that frailty
is not uncommon in middle-aged adults.
Frail subjects are characterized by rapid decline of func-
tional status even after minor perturbations and effective
interventions to prevent disability in frail older persons
who have been identified [15]. The identification of frail
middle-aged adults followed by effective interventions could
potentially prevent disability in older persons. Of note, given
the general lack of data on frailty among middle-aged adults,
there is currently no robust information on the impact of
frailty in middle-aged participants on health in later life.
However, given that frailty is a continuous process and that
the risk of adverse outcome is sought to increase gradually
from nonfrailty to prefrailty and frailty [2], it is likely that—
without intervention—frailty before age of 65 years increased
the risk of frailty and adverse outcome thereof after age of
65 years. Nevertheless, the natural history of frailty during
middle and late life course remains to be described in cohort
studies and the efficacy of interventions in middle-aged frail
adults determined by experimental studies.
We found a negative association betweenmonthly house-
hold income and the number of frailty indicators. Compared
to adults withmonthly household income<9,500CHF, adults
with monthly household income <5,000CHF were more
likely to have frailty indicators. This relationship persisted
after adjustment for major potential confounders including
age, gender, nationality, smoking, cardiovascular risk factors,
and chronic diseases as well as education level. Of note,
interaction of age with household income was statistically
significant, suggesting that the association of income with
frailty is not modified by age. Our results suggested that
the association with frailty is stronger among middle-aged
than older adults. We found no independent association with
education. Previous results on the associations of education
with frailty have been inconsistent [16, 17].
Previous data on SES and frailty have been collected
among people aged 65 years and over. Using a dataset from
a health survey of 4,000 people aged 65 years and over living
in all regions of Hong Kong, Woo et al. reported associations
of geographic districts and socioeconomic status with frailty
[18]; those of low SES had a higher risk of frailty. In the
Cardiovascular Health Study (CHS) Hirsch et al. found that
SESwas not associated with frailty amongAfricanAmericans
[19]. Yet a previous report of theCHS that includedCaucasian
and African American participants aged 65 or more found
that those who were frail had less education and lower
income [2]. Both income and education were independently
associated with incident frailty among the Women’s Health
Initiative study participants aged 65 to 79 [20]. In a cross-
sectional analysis of the Women’s Health and Aging studies
(women aged 65 years or more), low education and low
income were associated with frailty [8]. In an old adults
(70+ yrs) Mexican population, having a poor self-perceived
economic situation was more common in frail participants
[21]. In community-dwelling individuals aged 65 and older in
England, less wealth and greater neighborhood deprivation
were associated with greater frailty [22]. Finally, in a small
(𝑛 = 640) cross-sectional study of community-dwelling
persons aged 75 and older in Lleida, Spain, education was not
associated with frailty, while the association of frailty with
income approached statistical significance [23]. We found
that the association of income with frailty persisted after
adjustment for comorbidity. This observation challenges the
suggestion that social inequalities in frailty are mediated by
comorbidity [10].
The association of SES and income with frailty is of par-
ticular importance in a Swiss regionwith universal healthcare
coverage. Theou et al. recently reported that country level of
frailty is correlated with national economic indicators. Our
results highlight the fact that, even in a high-income country
such as Switzerland, frailty is associated with income [24].
Chronic diseases have been associated with frailty [25].
In our study, only hypertension was statistically significantly
associated with the number of frailty indicators. This is in
line with previous studies conducted among older adults
[2, 12]. Diabetes, myocardial infarction, angina pectoris, and
arterial obstruction were not associated. Compared to these
factors, hypertension was much more prevalent in our study
population and it is therefore possible that we lacked power
to detect associations for these less frequent factors.
Both BMI and waist-to-hip ratio were negatively associ-
ated with the number of frailty indicators. Frailty is concep-
tualized as a wasting disorder and sarcopenia is one of frailty
major pathophysiological features. Therefore our results are
concordant with the frailty syndrome. Yet, some previous
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studies found BMI and waist circumference to be positively
associated with frailty [11, 26].This relationship remains to be
better determined.
We found an inverse relationship between total choles-
terol and frailty. The relationships between lipid profiles and
frailty have rarely been explored [11]. In a study on 637
hospitalized old patients, Ranieri et al. concluded that lower
serum cholesterol levels were an independent hematologic
marker of frailty [27]. Low cholesterol level is a marker of
malnutrition and could therefore be noncausally associated
with frailty status. More recently, Schupf et al. also concluded
that low cholesterol level is a robust predictor of mortality in
nondemented old adults and may be a surrogate of frailty or
subclinical disease [28].
When interpreting the findings of this study, one has to
keep inmind its limitations.While four of the five frailty indi-
cators were collected using standard procedures, information
on walking speed was missing and conventional definition
of frailty syndrome (including prefrail and frail status) could
not be used. Also using the conventional definition of frailty
syndrome, having only one frailty indicator could perhaps
predict who would be frail in the future but does not identify
them as frail. All participants were assumed to have normal
walking speed and the prevalence of frailty is therefore
likely to be actually underestimated. Grip strength test was
performed on the right hand.While, for left-handed persons,
grip strength is considered equivalent in both hands, for
right-handed persons the dominant hand possesses 10%
greater grip strength than the nondominant hand [29].
Although significant efforts are made to avoid selection
bias (e.g., random sampling, multiple means to contact
potential participants, multiple recruitment sites including
outside the hospital using a mobile examination unit, and
no financial incentive), we cannot exclude that participants
differ from nonparticipants with respect to some attributes
that may potentially influence the presence or absence of
frailty indicators. Several participant characteristics were
determined by the use of questionnaires. By nature of its
reliance on self-reported data, this is a source of possible
bias. Due to the nature of information collected in the “Bus
Sante´” study (that collects information on cardiovascular
risk factors in the Canton of Geneva), only diabetes and
cardiovascular risk factors could be considered and not other
health conditions potentially associated with frailty, such as
other respiratory illnesses, arthritis, neurological disorders,
depression/mental health, and cognitive impairment. Given
the representativeness of the study sample, these conditions
are likely to be prevalent and may therefore confound some
of the associations reported. Also, we lack information on
education level, which may play an important role in frailty,
and cannot exclude that some of the associations reported are
explained—at least in part—by education level.
5. Conclusions
In a Swiss region with universal healthcare coverage, frailty
indicators are frequently encountered in both older and
middle-aged adults from the general population. Frailty is
partly reversible in its initial phase. This study identified
determinants of frailty that can help in identifying vulnerable
adults who could benefit from interventions to prevent
adverse health outcomes and disability.
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